Both in Biotechnology
Hemab Therapeutics Holdings vs Replimune Group
Over the past year COAG returned +5.2% and REPL returned +36.3%; their daily moves had a correlation of 0.38.
COAG +5.2% REPL +36.3%Growth of $1, one year, split-adjusted
| Metric | COAG | REPL |
|---|---|---|
| Price | $41.45 | $17.61 |
| Market cap | $1.94B | $1.67B |
| Today | +2.55% | +1.27% |
| 1 month | +33.5% | +30.9% |
| 6 months | — | +604.4% |
| Year to date | — | +81.2% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $457.5M | $183.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 79.7% |
| Short % of float | 20.4% | 29.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).